Liver cirrhosis is a chronic, progressive disease in which the liver becomes scarred and unable to work properly. The damage is caused by a variety of factors, including viral hepatitis , alcohol abuse, and nonalcoholic fatty liver disease. Symptoms include fatigue, weakness, weight loss, and abdominal swelling. Complications can include bleeding from dilated blood vessels in the esophagus and stomach, as well as liver cancer. Treatment options include lifestyle changes, medications, and in advanced cases, liver transplantation.

Causes of liver cirrhosis

The most common causes of liver cirrhosis are chronic alcohol abuse and viral hepatitis, specifically hepatitis B and C. Other causes include nonalcoholic fatty liver disease, inherited metabolic disorders, and certain medications. The accumulation of toxins and the body’s response to injury and inflammation lead to the formation of scar tissue, which over time can cause the liver to lose function.

Signs & symptoms of Liver Cirrhosis

The signs and symptoms of liver cirrhosis can include:

Fatigue

Weakness

Weight loss

Nausea

Loss of appetite

Abdominal swelling and pain

Itchy skin

Jaundice

Yellowing of the skin and eyes

Spider-like blood vessels on the skin

Easy bruising

Confusion or changes in mental function

However, these symptoms may not appear until the disease is advanced and significant liver damage has occurred. It is important to see a doctor early rather than late.

Evaluation of Liver Cirrhosis

The evaluation of liver cirrhosis typically involves a combination of medical history, physical examination, laboratory tests, and imaging studies.

Medical history

The patient's history of alcohol consumption, viral hepatitis, and other risk factors for liver disease will be evaluated.

Laboratory tests

Blood tests are used to evaluate liver function and check for anemia, clotting disorders, and infections. Biopsy of the liver may also be performed to confirm the diagnosis of cirrhosis and evaluate the severity of the disease.

Imaging studies

Imaging studies such as ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) can be used to evaluate the size and shape of the liver, as well as to detect any masses or fluid accumulation.

In addition to these evaluations, the assessment of liver cirrhosis also includes the use of non-invasive tests such as serum markers and/or Fibroscan to estimate the stage of fibrosis, which can guide the treatment approach.

Cirrhosis is usually an advanced stage of liver disease, and early diagnosis and treatment can prevent progression and improve outcomes.

Staging of Liver Cirrhosis

Staging of liver cirrhosis is a way to classify the severity of the disease and guide treatment decisions. There are several systems used to stage cirrhosis, but the most widely accepted is the Child-Pugh classification and the Model for End-Stage Liver Disease (MELD) score.

The Child-Pugh classification system uses five clinical and laboratory parameters to assign a score between A and C, with A indicating mild cirrhosis and C indicating severe cirrhosis.

The MELD score is a numerical scoring system that uses laboratory values of bilirubin, INR, and creatinine to predict the risk of death in patients with cirrhosis.

Both systems provide a general idea of the patient’s clinical status, prognosis, and the need for referral for liver transplantation, as well as the need for close monitoring and management of complications.

It is important to note that the staging systems are not mutually exclusive and both should be used in conjunction with other clinical, laboratory and imaging data to guide management and treatment decisions.

Medical treatment of Liver Cirrhosis

The medical treatment of liver cirrhosis is primarily aimed at managing the underlying cause of the disease, preventing further liver damage, and treating complications.

Treating the underlying cause

If the cause of cirrhosis is viral hepatitis, antiviral therapy may be recommended. If the cause is alcohol abuse, abstinence from alcohol is essential.

Preventing further liver damage

If the underlying cause of cirrhosis is not reversible, such as inherited metabolic disorders, then treatment is primarily focused on preventing further liver damage. This may include controlling risk factors such as obesity, diabetes and hypertension.

Treating complications

Cirrhosis can lead to a variety of complications such as portal hypertension, ascites, and hepatic encephalopathy. These complications can be treated with medications such as diuretics, beta-blockers, and lactulose.

Nutrition

Patients with cirrhosis may require a special diet that is low in sodium, protein and fat.

Vaccination

Patients with cirrhosis should be vaccinated against hepatitis A and B.

Monitoring

Patients with cirrhosis should be monitored regularly by a liver specialist to detect any complications early and manage them appropriately.

It is important to note that in cases of advanced cirrhosis, liver transplantation may be the only treatment option.

Liver transplant

Liver transplantation is an operation in which a damaged or diseased liver is removed and replaced with a healthy liver from a deceased ( brain dead ) or living related donor. This is recommended for patients with end-stage liver disease who have failed to respond to other forms of treatment and have a poor prognosis without a transplant.

Before a transplant can take place, the patient must be evaluated to determine if he / she is a suitable candidate. This includes a thorough medical examination, laboratory tests, and imaging studies. The patient’s overall health, the severity of their liver disease, and the availability of a suitable donor liver are all considered when determining if a transplant is appropriate.

The transplant operation is performed under general anesthesia and can take anywhere between 7 – 12 hours. The patient’s own liver is removed, and the new liver is carefully implanted and connected to the patient’s blood vessels and bile ducts (implantation or ‘plumbing’).

After the transplant, the patient will be closely monitored in the intensive care unit ( Liver ICU )  for several days. They will need to take immunosuppressive medications to prevent rejection of the new liver, and they will also need to make lifestyle changes such as avoiding alcohol and certain medications.

During the period post-transplant, the patient will need to be closely monitored for any signs of rejection and infection, as well as for any side effects of the immunosuppressive medications.

Liver transplantation can be a life-saving procedure for patients with end-stage liver disease. The success of the transplant is usually over 90% , but depends on various factors.